ID: ALA4098228

Max Phase: Preclinical

Molecular Formula: C23H32N3NaO9S

Molecular Weight: 527.60

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)OC([C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)S(=O)(=O)[O-].[Na+]

Standard InChI:  InChI=1S/C23H33N3O9S.Na/c1-14(2)11-18(26-23(30)34-13-16-7-5-4-6-8-16)21(29)25-19(12-17-9-10-24-20(17)28)22(35-15(3)27)36(31,32)33;/h4-8,14,17-19,22H,9-13H2,1-3H3,(H,24,28)(H,25,29)(H,26,30)(H,31,32,33);/q;+1/p-1/t17-,18-,19-,22?;/m0./s1

Standard InChI Key:  WIIKBMBOAVOAED-FIGVUBRSSA-M

Associated Targets(non-human)

Norovirus 313 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 527.60Molecular Weight (Monoisotopic): 527.1938AlogP: 1.12#Rotatable Bonds: 12
Polar Surface Area: 177.20Molecular Species: ACIDHBA: 8HBD: 4
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: -1.06CX Basic pKa: CX LogP: -0.12CX LogD: -1.40
Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.23Np Likeness Score: 0.35

References

1. Galasiti Kankanamalage AC, Kim Y, Rathnayake AD, Alliston KR, Butler MM, Cardinale SC, Bowlin TL, Groutas WC, Chang KO..  (2017)  Design, Synthesis, and Evaluation of Novel Prodrugs of Transition State Inhibitors of Norovirus 3CL Protease.,  60  (14): [PMID:28671827] [10.1021/acs.jmedchem.7b00497]

Source